Tevogen Bio Holdings Inc (TVGN) 뉴스

See $4 zone ($4.20$4.54) as resistance now with the news eliminating debt and liabilities. Moves up slowly..
Tevogen reiterated its confidence in its financial stability, confirming sufficient available capital to fund operations for at least the next 33 months, supported by a loan agreement, which Tevogen entered into in June. Additionally, Tevogen eliminated almost all of its liabilities which were $99.9 million as reported at December 31, 2023 and now are $10.5 million as reported at September 30, 2024.





Tevogen’s internally developed intellectual property and product assets, valued internally at $10 billion+ using discounted cash flow models, are not reflected on the balance sheet. Due to US GAAP accounting rules, the company was unable to report the fair market value of its assets, including proprietary immunotherapy technologies and cutting-edge artificial intelligence platforms. The company believes that the inclusion of Tevogen’s IP assets on its balance sheet would significantly enhance its enterprise value



Commenting on the company’s performance and unique ownership structure, Dr. Saadi concluded, “Tevogen’s leadership stands apart in the biotech sector, with approximately 78% of equity retained by our officers, an extraordinary figure compared to the industry average of just 4%. In addition to our officers, our key employees have also been granted substantial restricted stock units in the company, reflecting our belief that our employees should also be owners of our success.”

TVGN.........................................https://stockcharts.com/h-sc/ui?s=TVGN&p=W&b=5&g=0&id=p86431144783

TVGN..........................................https://stockcharts.com/h-sc/ui?s=TVGN&p=W&b=5&g=0&id=p86431144783

Looks interesting

TVGN..................https://stockcharts.com/h-sc/ui?s=TVGN&p=W&b=5&g=0&id=p86431144783

$1.32 + 10% .. WARREN, N.J., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, nears finalization of agreement with CD8 Technology for a turn-key facility intended to support both pre-clinical research and GMP manufacturing capabilities, staffed by Tevogen.

Adding 

https://www.stocktitan.net/news/TVGNW/tevogen-bio-expands-on-microsoft-partnership-to-integrate-machine-zepglnzxz4n7.html

Yes sir

Is it true they are partners with Microsoft?

I think I messed up. I'm sitting on 555 @ average 2.58 I really did not want to be stuck in that overnight. Thoughts?

Flip out some $2.60s 

Back in $2.20s for a flip maybe quick hopefully longer 

Not much pumped some premarket so always careful have to see if $2.29- $2.47 zone holds afee profit taking then will add some perhaps 

Can you explain what that means for me? Im new TY

TVGN 3.20 trading float about 21m about 15m traded so far 

TVGN $4s coming will trade whole float by 930am

Tevogen Bio To Provide Timelines Associated with Recently Announced Revenue Forecast and Updates on Operational Readiness This WeekOctober 22 2024 - 2:30PM


Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, plans to provide further updates on the previously announced revenue forecast for Tevogen Oncology and Tevogen Specialty Care therapeutic areas by the end of this week. The revenue forecast for the two therapeutic areas is approximately $1 billion each in their respective launch years. The 5-year combined estimate for the two therapeutic areas is between $28 billion and $36 billion.Tevogen Bio also plans to update shareholders on Tevogen AI, its proprietary artificial intelligence effort, designed to advance a mission to lower the total cost of drug development, expedite drug discovery, and deliver life-changing therapies to large patient populations. In addition, Tevogen Bio will provide an update on clinical and commercial manufacturing.

TVGN 3.75 -3.88 zone up there and then $4.27 on high side in the 2.62-3.40 zone for now

tvgn............................https://stockcharts.com/h-sc/ui?s=tvgn&p=W&b=5&g=0&id=p86431144783

Actually buying more tomorrow, price targets changed 16-18 dollars by year end.

In less than 2 years CVNA went absolutely nuts wow!!!
TVGN

#TVGN 🔥 70% short interest & $TVGN squeezing! watch this week!

thanks

SAVE could do similar pattern as CVNA did.

For me personally not going to wait 10-12. I will sell at $6.00

SAVE - when to 10 - 12 $ and who is selling all those shares?

SAVE will run big 10-12 dollars

Wow uavs!!!!
save still ok ?
TVGN

It was a great setup, I was looking for the Microsoft deal to come through and it did. Made my move on SAVE and UAVS.

No loaded 4000 shares this morning, it should run to 7-8 dollars but it will get to 10-12 dollar range. Float is next to nothing. They have contracts with the French Army and the United Nations. Severly undervalued.

Wow that chart looks hot hot hot..lol
Just got some…waiting for updates?
TVGN

TVGN 2.90 time to flip this champ again. Happy trading 

Buy UAVS too.

Great call dino…we’re making $$$ so far!!!!
OSS

MSFT deal $2.50 +50%

Moon soon. A lot of headwinds

This should go much higher than five: "..... Dr. Saadi added, "I was pleased that Tevogen was able to provide updates on the Company, including our pipeline, our $1 billion launch year oncology guidance, and I expect to share more details on further progress in the coming days."....."

Got it

Why can I not uy Tvgn?

SOUNDS AWESOME $TVGN IS READY

TVGN.............................https://stockcharts.com/h-sc/ui?s=TVGN&p=W&b=5&g=0&id=p86431144783

Showtime! Momentum , great news, and more news this week!

$$$

:)

Let’s do this !

TVGN heading to $5.00 this week, don’t miss it. Nice PR!!!!!!!! Boom time.

looks $TVGN News from Saturday , should moving....💪
🔥🔥🔥🔥🔥 imho

$5.00 by the end of the week.

The “After, after hours” news release Friday night from the CEO isn’t even priced in yet. Further reinforcing the multi billion, multi year projections and even telling us more news releases within days! This is un precedented, un paralleled and it’s working! The stock price is going up. To me Tevogen’s past two weeks is exactly how the stock market is supposed to work. And I anticipate making $15K here across the next 5 trading days.

Markets are hot right us!

Us longs deserve to make some bank this year!!! GLTA

News from CEO was released Friday after get, after hours closing! Market hasn’t even seen the upside priced in, leads me to anticipate up $2+ pre market easily!

$$$

:)

Let’s do this!

#TVGN 🔥 nice uptrend with high short interest and good volume! watch this week $TVGN

#TVGN 🔥 nice uptrend with high short interest and good volume! watch this week $TVGN